Cargando…

Chemotherapy combined with radiotherapy can benefit more unresectable HCC patients with portal and/or hepatic vein invasion: a retrospective analysis of the SEER database

BACKGROUND: The purpose of this study is to evaluate the effects of chemotherapy and radiotherapy on the prognosis of unresectable HCC patients with portal and/or hepatic vein invasion. METHODS: A retrospective analysis of unresectable HCC patients with portal and/or hepatic vein invasion registered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Xiaotong, Cai, Jianye, Chen, Haitian, Yao, Jia, Xiao, Cuicui, Li, Rong, Xiao, Jiaqi, Zhang, Jiebin, Sui, Xin, Lu, Tongyu, Zheng, Jun, Zhang, Yingcai, Yang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319410/ https://www.ncbi.nlm.nih.gov/pubmed/37409255 http://dx.doi.org/10.3389/fonc.2023.1098686

Ejemplares similares

Causal associations between changes in lipid profiles and risk of gallstone disease: a two-sample Mendelian randomization study
por: Yuan, Xiaofeng, et al.
Publicado: (2022)

Administration of AG490 decreases the senescence of umbilical cord-mesenchymal stem cells and promotes the cytotherapeutic effect in liver fibrosis
por: Jiang, Chenhao, et al.
Publicado: (2023)

Macroscopic Portal Vein Thrombosis in HCC Patients
por: Akkiz, Hikmet, et al.
Publicado: (2018)

Portal Vein Thrombosis in Unresectable Hcc Cases: a Single Center Study of Prognostic Factors and Management in 140 Patients
por: Abdelmaksoud, Ahmed Hosni, et al.
Publicado: (2017)

External Radiation versus Internal Radiation for Patients with Advanced Unresectable HCC -A SEER Based Study
por: Wang, Xuan, et al.
Publicado: (2019)

Heat shock preconditioning mesenchymal stem cells attenuate acute lung injury via reducing NLRP3 inflammasome activation in macrophages
por: Lv, Haijin, et al.
Publicado: (2021)

CircFOXK2 promotes hepatocellular carcinoma progression and leads to a poor clinical prognosis via regulating the Warburg effect
por: Zheng, Jun, et al.
Publicado: (2023)

Conversion Therapy of Large Unresectable Hepatocellular Carcinoma With Ipsilateral Portal Vein Tumor Thrombus Using Portal Vein Embolization Plus Transcatheter Arterial Chemoembolization
por: He, Chengjian, et al.
Publicado: (2022)

An Integrated Nomogram Combining Clinical Factors and Microtubule-Associated Protein 1 Light Chain 3B Expression to Predict Postoperative Prognosis in Patients with Intrahepatic Cholangiocarcinoma
por: Chen, Liang, et al.
Publicado: (2020)

Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Protect Liver Ischemia/Reperfusion Injury by Reducing CD154 Expression on CD4+ T Cells via CCT2
por: Zheng, Jun, et al.
Publicado: (2020)

Application of associating liver partition and portal vein ligation for staged hepatectomy for initially unresectable hepatocellular carcinoma
por: Chen, Haoqi, et al.
Publicado: (2022)

Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
por: Nakazawa, Takahide, et al.
Publicado: (2014)

Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion
por: Takeda, Haruhiko, et al.
Publicado: (2019)

Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis
por: Chen, Jifan, et al.
Publicado: (2020)

Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?
por: Luo, Laihui, et al.
Publicado: (2022)

Hepatic arterial infusion of oxaliplatin plus raltitrexed in unresectable hepatocellular carcinoma with or without portal vein tumour thrombosis
por: Chen, Shiguang, et al.
Publicado: (2022)

Tumor Regression in HCC Patient with Portal Vein Tumor Thrombosis after Intraportal Radiofrequency Thermal Ablation
por: Mizandari, Malkhaz, et al.
Publicado: (2016)

Short-term and long-term outcomes of liver resection for HCC patients with portal vein tumor thrombus
por: Huo, Lei, et al.
Publicado: (2019)

Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival
por: Somma, Francesco, et al.
Publicado: (2019)

INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus
por: Song, Xiaodong, et al.
Publicado: (2020)

TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study
por: Yang, Biao, et al.
Publicado: (2021)

Effectiveness of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Portal Vein and/or Inferior Vena Cava Tumor Thrombosis
por: Xi, Mian, et al.
Publicado: (2013)

Hypofractionated Radiotherapy for Palliation of Main Portal Vein Tumor Thrombosis
por: Fang, Fang, et al.
Publicado: (2022)

Combination of sorafenib and TACE inhibits portal vein invasion for intermediate stage HCC: a single center retrospective controlled study
por: Yao, Qi, et al.
Publicado: (2017)

Totally laparoscopic associating liver partition and portal vein ligation for staged hepatectomy using anterior approach in HCC patient with Type II portal vein anomaly: a case report
por: Ha, Heon Tak, et al.
Publicado: (2017)

Radiomics-Based Prediction of Future Portal Vein Tumor Infiltration in Patients with HCC—A Proof-of-Concept Study
por: Stoehr, Fabian, et al.
Publicado: (2022)

Effect of radiotherapy on the survival of cervical cancer patients: An analysis based on SEER database
por: Yang, Jian, et al.
Publicado: (2019)

Successful Management of an “Unresectable” Intrahepatic Cholangiocarcinoma with Neoadjuvant Systemic Therapy, Chemoembolization, and Extended Hepatectomy with Portal Vein Reconstruction
por: Cantrell, Colin K, et al.
Publicado: (2018)

Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience
por: Patidar, Yashwant, et al.
Publicado: (2021)

Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
por: Salem, Riad, et al.
Publicado: (2021)

Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis
por: Dong, Gang, et al.
Publicado: (2021)

The role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus
por: Yeh, Shyh-An, et al.
Publicado: (2015)

The Degree of Lipiodol Accumulation Can Be an Indicator of Successful Treatment for Unresectable Hepatocellular Carcinoma (HCC) Patients - in the Case of Transcatheter Arterial Chemoembolization (TACE) and External Beam Radiotherapy (EBRT)
por: Yang, Ping, et al.
Publicado: (2016)

Evaluation of the Efficacy and Toxicity of Radiotherapy for Type III-IV Portal Vein Tumor Thrombi
por: Bai, Shuheng, et al.
Publicado: (2021)

Anomalous duplication of the portal vein with prepancreatic postduodenal portal vein
por: Kitagawa, Sho
Publicado: (2022)

Analysis of related factors of portal vein thrombosis in liver cirrhosis
por: Xu, Xiaotong, et al.
Publicado: (2023)

Effectiveness and tolerability of camrelizumab combined with molecular targeted therapy for patients with unresectable or advanced HCC
por: Li, Ting, et al.
Publicado: (2023)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
por: Yu, Su Jong, et al.
Publicado: (2023)

A Large Portal Vein: A Rare Finding of Recent Portal Vein Thrombosis
por: Qi, Xingshun, et al.
Publicado: (2011)

Stereotactic Percutaneous Electrochemotherapy as Primary Approach for Unresectable Large HCC at the Hepatic Hilum
por: Luerken, L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pfudc7qd7eq3adain0rmf6klv1